Nardosinone Alleviates Parkinson’s Disease Symptoms in Mice by Regulating Dopamine D2 Receptor

Figure 10

Hypothesis for the mechanism of action of nardosinone in relieving Parkinson’s symptoms. (Through the circulation of the human body, nardosinone passes through the blood-brain barrier, enters the brain and binds with DRD2 receptor, and plays a role by regulating multiple signaling pathways.)